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Actin requires the chaperonin containing 
TCP1 (CCT), a hexadecameric ATPase 
essential for cell viability in eukaryotes, to 
fold to its native state. Following binding of 
unfolded actin to CCT, the cavity of the 
chaperone closes and actin is folded and 
released in an ATP-dependent folding cycle. 
In yeast, CCT forms a ternary complex with 
the phosducin-like protein PLP2p to fold 
actin, and together they can return nascent or 
chemically denatured actin to its native state 
in a pure in vitro folding assay. The 
complexity of the CCT-actin system makes 
the study of the actin folding mechanism 
technically challenging. We have established a 
novel spectroscopic assay through selectively 
labeling the C-terminus of yeast actin with 
acrylodan and observe significant changes in 
the acrylodan fluorescence emission spectrum 
as actin is chemically unfolded and then 
refolded by the chaperonin. The variation in 
the polarity of the environment surrounding 
the fluorescent probe during the 
unfolding/folding processes has allowed us to 
monitor actin as it folds on CCT. The rate of 
actin folding at a range of temperatures and 
ATP concentrations has been determined for 
both wild type CCT and a mutant CCT, 
CCT4anc2 defective in folding actin in vivo. 
Binding of the non-hydrolysable ATP 
analogue AMP-PNP to the ternary complex 
leads to threefold faster release of actin from 
CCT following addition of ATP, suggesting a 
two-step folding process with a 
conformational change occurring upon 
closure of the cavity and a subsequent final 
folding step involving packing of the C-
terminus to the native-like state.  
 
The cytoskeletal protein actin is one of the most 
highly conserved in all eukaryotes and is 
involved in many essential cellular processes 
such as cell motility and cytokinesis. It exists in 
two forms: at low ionic concentrations, the G-
actin monomer is stable, whereas in the presence 
of KCl, MgCl2 or CaCl2 and ATP, the F-actin 
polymer predominates. The actin monomer 
consists of two domains, the so-called large 
domain and the small domain, which surround a 
nucleotide binding cleft and a high affinity 
divalent cation binding site (1). Actin can be 
further divided into subdomains, with the N- and 
C-termini co-located at the base of subdomain 1 
(Fig. 1). G-actin can be unfolded thermally or 
chemically in the presence of denaturant or 
EDTA. Studies of the unfolding kinetics of 
rabbit skeletal muscle α-actin (ActA) with 
EDTA have shown that following loss of the 
cation and nucleotide from native actin, the actin 
then unfolds to an intermediate I3, which cannot 
refold spontaneously (2) (Eq. 1). Unfolding actin 
by EDTA treatment allows folding studies to be 
performed under physiological conditions.  
N.ATP.Ca2+ I1.ATP + Ca
2+ I2 + ATP I3→← →← → (1)
In eukaryotic cells, nascent actin is folded by the 
cytosolic chaperonin containing TCP1 (CCT or 
TRiC for TCP1-ring complex). CCT is a 1 MDa 
protein complex made up of two rings, each of 
which consists of 8 different subunits, known as 
CCTα – CCTθ in mammals and CCT1 – CCT8 
in yeast. Recent studies of the CCT interactome 
have revealed a wide number of interacting 
proteins within the cell (3, 4), although only a 
limited number of obligate substrates have been 
characterized, including actin and tubulin as well 
as a number of WD40 repeat containing proteins 
(5). Actin folding by CCT in vivo in yeast 
requires the phosducin-like protein PLP2p (6), 
which contains a thioredoxin fold and forms a 
stable ternary structure with actin and CCT in 
vitro (7). The precise manner by which PLP2p 
assists actin folding is as yet unknown; PLP2p 
may be involved in the initial loading of actin 
onto CCT and ensuring that the correct 
engagement is reached, and/or it could have a 
role during folding or release. Although both 
EDTA-unfolded ActA and S. cerevisiae actin 
(Act1) can be bound by yeast CCT only Act1 
can be productively refolded, indicating species-
specific differences in actin folding behaviour 
and providing compelling evidence for the 
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absolute dependence of actin on CCT for its 
folding to the native state (8).  
Here, we discuss the development of a 
spectroscopic actin folding assay which allows 
actin folding by CCT to be monitored in real 
time through labeling with the environmentally 
sensitive dye acrylodan. This approach allows 
greater sensitivity in the measurement of actin 
folding kinetics than gel electrophoresis-based 
assays, and has been used to observe the effects 
of ATP concentration and temperature on the 
rate of actin folding. Actin folding by 
CCT4anc2, a mutated form of CCT found in the 
temperature sensitive yeast strain anc2-1 (9), has 
also been investigated. We present evidence for 
an actin folding intermediate within a functional 
folding cycle.  
 
EXPERIMENTAL PROCEDURES 
Purification and Labeling of Act1- Act1 was 
purified from S. cerevisiae lysate by affinity 
chromatography using a DNase I-Affigel column 
followed by ion exchange chromatography (10). 
The purified protein was eluted with 
approximately 220 mM KCl, and was 
polymerized by addition of 1 mM ATP and 2 
mM MgCl2 and incubation on ice for 30 min. A 
five-fold molar excess of Alexa Fluor 488-C5-
maleimide (Invitrogen) or a twenty-fold molar 
excess of acrylodan (Anaspec) was added to the 
polymerized actin and incubated on ice 
overnight. The labeled actin was centrifuged (2 
h, 4°C, 100 000 x g) then the pellet was 
resuspended in 10 mM Tris pH 7.5, 0.5 mM β-
mercaptoethanol, 0.2 mM CaCl2, 50 μM ATP 
and dialyzed against the same buffer for 70 h at 
4°C. After centrifugation, the supernatant was 
collected and the actin concentration and degree 
of labeling were calculated using the extinction 
coefficient 26 600 M-1cm-1 for actin at 290 nm 
(2), 18 500 M-1cm-1 for acrylodan at 385 nm 
(11), and 71 000 M-1cm-1 for Alexa Fluor 488 at 
494 nm (2). Labeling efficiencies of 60 - 80 % 
and 92 % were obtained for AcrylAct1 and 488Act1 
respectively.  
Purification of CCT- CCT and CCT4anc2 were 
purified through a calmodulin binding peptide 
(CBP) tag inserted into subunit CCT3 (12). S. 
cerevisiae lysate expressing the tagged CCT was 
bound to calmodulin resin (Stratagene) and 
washed firstly with 20 mM HEPES pH 8, 1 M 
NaCl, 2 mM CaCl2, 1 mM TCEP, 0.01 %v/v 
lauryldimethylamine oxide (LDAO), 20 %v/v 
glycerol, 5 mM ATP, 0.5 mM ADP, 15 mM 
MgCl2, followed by two washes with 20 mM 
HEPES pH 8, 150 mM KCl, 0.1 mM CaCl2, 1 
mM TCEP, 0.01 %v/v LDAO, 20 %v/v glycerol, 
5 mM ATP, 0.5 mM ADP, 15 mM MgCl2 and a 
final wash with 20 mM HEPES pH 8, 150 mM 
KCl, 0.1 mM CaCl2, 1 mM TCEP, 0.01 %v/v 
LDAO, 20 %v/v glycerol. CCT was eluted with 
20 mM HEPES pH 8, 150 mM KCl, 2 mM 
EGTA, 1 mM TCEP, 0.01 %v/v LDAO, 20 
%v/v glycerol. To ensure that only the intact 
complex was isolated, CCT was further purified 
by sucrose gradient (20 mM HEPES pH 8, 150 
mM KCl, 1 mM TCEP, 0.01 %v/v LDAO, 15 
%v/v glycerol, 10 – 37.5 %w/v sucrose). The 
CCT containing fractions were concentrated, and 
the concentration was determined using the 
extinction coefficient 320 240 M-1 cm-1 at 280 
nm (7).  
Purification of PLP2p- Polyhistidine (6His)-
tagged PLP2p was expressed in BL21(DE3) E. 
coli cells and purified by affinity 
chromatography using His-Spin Protein 
Miniprep columns (Zymo Research). After 
washing with His-Binding Buffer (50mM 
sodium phosphate pH 7.8, 300 mM NaCl, 10 
mM imidazole, 0.03 % Triton X-100), PLP2p 
was eluted from the column with His-Elution 
Buffer (50mM sodium phosphate pH 7.8, 300 
mM NaCl, 250 mM imidazole) and dialysed into 
20mM HEPES pH 8, 75 mM KCl.  
Polymerization of AcrylAct1- AcrylAct1 (8.5 μM, 
0.35 mg/ml) was incubated at room temperature 
in the presence of 100 mM KCl, 2 mM MgCl2, 1 
mM ATP.  
Unfolding of AcrylAct1- AcrylAct1 was diluted in 
20mM HEPES pH 8, 75 mM KCl, 1 mM TCEP, 
2 μM ATP to concentrations of no more than 18 
μg/ml (440 nM). Unfolding was carried out at 
24°C by addition of 1.5 mM EDTA.  
488Act1 Folding Assay- 488Act1 (6.5 μg/ml, 160 
nM) was unfolded in the presence of CCT (460 
μg/ml, 460 nM) and PLP2p (15 μg/ml, 450 nM) 
in 20 mM HEPES pH 8, 75 mM KCl, 1 mM 
TCEP, 1.5 mM EDTA, 10 %v/v glycerol. 
Samples were protected from light and incubated 
at room temperature for 3 h. For release from 
CCT, 2 mM ATP and 10 mM MgCl2 were added 
and the mixture was incubated at 30°C. Samples 
for gels were added to 20 mM HEPES pH 8, 10 
%v/v glycerol, 1 mM CaCl2 and kept on ice until 
loading onto a 6% native polyacrylamide gel 
containing 1 mM ATP. (7)  
AcrylAct Folding Assay- AcrylAct1 or AcrylActA 
(14.4 μg/ml, 350 nM) was unfolded for 3 h in 
the presence of CCT or CCT4anc2 (400 μg/ml, 
400 nM) and PLP2p (13.5 μg/ml, 400 nM) as for 
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488Act1. ATP and MgCl2 were added so that the 
final concentrations were 1, 2 or 4 mM ATP, and 
5, 10 or 20 mM MgCl2 respectively, with the 
final glycerol concentration at 8 %v/v. Folding 
was monitored spectroscopically, either by 
repeatedly scanning the fluorescence emission of 
the sample or by monitoring emission at 470 nm 
for the duration of the reaction. 
Co-polymerisation of 488Act1 and AcrylAct1 with 
unlabeled Act1- Refolded AcrylAct1 or 488Act1 
was incubated overnight on ice with Act1 to a 
final Act1 concentration of 250 µg/ml (6 µM) in 
the presence of 115 mM KCl, 1.7 mM ATP and 
6 mM MgCl2. After centrifugation (2 h, 4°C, 100 
000 x g), the pellet was analysed by SDS PAGE. 
AMP-PNP Actin Folding Assay- AcrylAct1 or 
488Act1 were unfolded as described previously. 
Adenylyl imidodiphosphate (AMP-PNP) and 
MgCl2 were added to final concentrations of 10 
mM and 50 mM respectively, and samples were 
incubated at 30°C for 10 min. After this time, 
ATP or ADP and MgCl2 were added so that the 
final concentrations were 8 mM AMP-PNP, 2 
mM ATP or ADP, 50 mM MgCl2, 70 mM KCl, 
8 %v/v glycerol, 0.64 mM TCEP and folding 
was monitored either spectroscopically for 
AcrylAct1 or by native PAGE for 488Act1.  
Fluorescence measurements- Fluorescence 
emission was measured with the PTI 
QuantaMaster 40 spectrofluorometer with a 
Haake DC10-K15 refrigerated circulator 
attached. The excitation wavelength used was 
380 nm, and the excitation slits were set to 2 nm. 
Emission spectra were collected from 425 - 525 
nm, and time-based emission was monitored at 
470 nm with the emission slits set to 4 nm.  
Data Analysis- The change in the intensity of 
acrylodan fluorescence emission at 470 nm over 
time was fitted to a single exponential using 
GraphPad Prism 5 (GraphPad Software), with 
the first 50 seconds of time-based scans being 
excluded since a mixing phase could be seen. 
Rate constants were calculated as the mean of at 
least three independent experiments with error 
bars representing the standard deviation.  
 
RESULTS 
Acrylodan Labeling and Chemical Unfolding of 
Act1. Dye labeling of Act1 at Cys374 has a large 
impact on the kinetics of chemical unfolding 
with EDTA, resulting in much more rapid 
unfolding of the labeled protein to the I3 state in 
comparison to unlabeled Act1. This is a useful 
experimental property since yeast actin unfolds 
on a much slower time-scale than ActA, taking 
several hours to denature completely (2, 7). 
Actin was selectively labeled at Cys374 by 
polymerization followed by incubation with 
Alexa Fluor 488 or acrylodan, a thiol-reactive 
derivative of Prodan. Cys374 is located in a 
flexible stretch of residues at the C-terminus of 
actin which packs against subdomain 1 in the 
crystal structure of the actin-rhodamine dye 
complex (1) (Fig. 1).  
Prodan, which has an emission maximum of 531 
nm in water (13), is highly sensitive to changes 
in its environment. In less polar solvents than 
water a blue shift in emission, accompanied by a 
large increase in the fluorescence intensity, 
occurs and this allows changes in the 
environment of the probe to be monitored 
spectroscopically. The emission of native 
acrylodan-labeled Act1 (AcrylAct1NAT) is 
dramatically different to that of EDTA-unfolded 
AcrylAct1 (AcrylAct1I3), which has a very similar 
emission spectrum to CCT-bound AcrylAct1 (Fig. 
2A). The maximum emission wavelength for 
AcrylAct1NAT is at 489 nm, and the Stokes shift of 
this form is 98 nm, in contrast to the EDTA-
unfolded protein which exhibits maximum 
fluorescence emission at 463 nm and has a 
Stokes shift of 81 nm. Interestingly, the 
maximum emission wavelength of the unfolded 
AcrylAct1 is very similar to the value of 465 nm 
reported for acrylodan-labeled rabbit skeletal 
muscle F-actin (14), indicating that the 
environment in which the dye is found in F-actin 
is similar to that of the CCT-bound AcrylAct1. 
Within acrylodan-labeled yeast F-actin, 
fluorescence emission is also observed to be 
blue-shifted (Fig. 2B), although not to the same 
extent as that of the acrylodan-labeled rabbit F-
actin (14). This could reflect only partial 
incorporation of AcrylAct1 into the filaments, 
however it is known that actin labeled in this 
manner is capable of polymerisation since that is 
how it is purified. This blue shift in fluorescence 
emission in the unfolded, CCT-bound and 
polymerized AcrylAct1 indicates that the probe is 
in a less polar environment in all these three 
states compared to the native G-actin monomer.  
The rate of EDTA unfolding of AcrylAct1NAT was 
determined by fitting a single exponential to the 
fluorescence emission at 470 nm (Fig. 2C). This 
gives the observed rate constant for the 
unfolding reaction to be 1.48 x 10-3 ± 0.09 x 10-3 
s-1 in the presence of the 10 % v/v glycerol 
required to stabilize CCT. Stopped flow analysis 
of the unfolding kinetics of rabbit skeletal 
muscle actin revealed a transition through 
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intermediates (2), such as the calcium free, ATP 
bound intermediate I1, which is not visible in this 
analysis of yeast actin unfolding. This could be 
due to the short time scale over which this 
transition takes place relative to the mixing time. 
Alternatively, it is also possible that the calcium-
unbinding transition does not affect the local 
environment surrounding the fluorescent probe 
at the C-terminus to the same degree as the four 
tryptophan residues in subdomain 1 that 
constitute the entire intrinsic fluorescence signal 
of actin (2).  
Release of Fluorescently Labeled Act1 from 
CCT. It has been shown that CCT can form a 
stable ternary complex with 488Act1 and PLP2p 
following chemical unfolding of 488Act1NAT with 
EDTA, and that upon addition of ATP and 
MgCl2 native 488Act1 can be released in the pure 
in vitro folding assay system (7) (Fig. 3A). We 
then experimented with various environment-
sensitive probes but found that some labeled 
actins behaved differently with respect to release 
from CCT; for example Act1, fluorescently 
labeled with 5-((2-
((iodoacetyl)amino)ethyl)amino)naphthalene-1-
sulfonic acid (IAEDANS), AEDANSAct1, could be 
loaded onto CCT, but native AEDANSAct1 could 
not be released from the complex (data not 
shown). In contrast, AcrylAct1 could be loaded 
onto CCT and released in the same manner as 
488Act1 (Fig. 3B). It can be seen by native 
polyacrylamide gel electrophoresis (native 
PAGE) that the folding reaction is complete 
within approximately 10 minutes, and around 90 
% of actin is released. The refolded AcrylAct1 can 
be bound by DNase I and vitamin D binding 
protein (VDBP) (Fig. 3B), and copolymerized 
with unlabeled actin (Fig. 3D), demonstrating 
that native G-actin is formed (7). Further support 
for the natural behaviour of the folding system 
used here is that it is unable to fold AcrylActA to 
the native state (Fig. 3C). This had only 
previously been shown in the coupled IVT 
transcription/translation system (8) but is a 
property of this pure component system as well.  
Upon addition of ATP and MgCl2 to the 
AcrylAct1-CCT-PLP2p complex, a decrease in 
acrylodan emission accompanied by a shift in 
the maximum emission wavelength is observed 
(Fig. 2A and 4A), thereby allowing the folding 
reaction to be monitored spectroscopically. This 
shift occurs over a similar time period to the 
release of native actin from CCT as observed by 
native PAGE, and as such can be used to make 
more accurate measurements of the rate of 
release from the chaperonin. A single 
exponential can be fitted to the decrease in 
emission as AcrylAct1 is released from CCT (Fig. 
4A). The observed rate constant of release (k) of 
AcrylAct1 from CCT over a range of temperatures 
was determined based on fluorescence emission 
at 470 nm. By fitting of these rate constants to 
the Arrhenius equation (Fig. 4B), the activation 
energy of actin release by CCT was found to be 
34 ± 8 kJ mol-1, 32 ± 8 kJ mol-1 and 29 ± 19 kJ 
mol-1 for 4 mM, 2 mM and 1 mM ATP 
respectively. It can be seen that although both 
temperature and the concentration of ATP have 
an effect on the rate of release of AcrylAct1, the 
temperature dependence appears similar over the 
different ATP concentrations indicating that the 
reaction is proceeding by the same mechanism.  
The spectroscopic folding assay was not 
performed using 488Act1 as only a very small 
change in the fluorescence emission is observed 
upon unfolding (2) and since a mixture of states 
exist during the folding process, the changes in 
intensity would be too small to accurately 
measure. 
Release of Act1 from CCT4anc2. CCT4anc2 
contains the mutation G345D in subunit CCT4, 
located in the external region of the apical 
domain, and causes actin defects in the 
temperature sensitive yeast strain anc2-1 (9, 15). 
Using the spectroscopic folding assay, the rate of 
release of AcrylAct1 by CCT4anc2 was found to 
be the same as for CCT at 2 mM ATP; however 
different behaviour was observed at the higher 
ATP concentration. At 4 mM ATP the rate of 
release of AcrylAct1, while faster than from the 
mutant at 2 mM ATP, was slower than that from 
wild-type CCT. Furthermore, the rate of release 
increased with temperature up to 32.5°C, but at 
temperatures above this there was a subsequent 
decrease in the rate of release (Fig. 5), consistent 
with the heat-sensitive behaviour in vivo of 
CCT4anc2 mutant cells (9, 15).  
Release of Act1 from CCT following addition of 
AMP-PNP. Addition of the non-hydrolysable 
ATP analogue AMP-PNP to CCT-bound 
AcrylAct1 had no significant effect on the 
acrylodan emission spectrum. However, upon 
addition of ATP to a final concentration of 2 
mM, actin release could be seen to occur at a 
faster rate than observed when ATP was added 
directly to the AcrylAct1-CCT complex in the 
absence of AMP-PNP (Fig. 6A). Fitting of a 
single exponential to the decrease in 
fluorescence gave an observed rate constant k of 
11.8 x 10-3 ± 0.7 x 10-3 s-1, which is an 
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approximately three-fold increase relative to the 
release of AcrylAct1 from CCT without the pre-
incubation step (3.8 x 10-3 ± 0.3 x 10-3 s-1). 
Following addition of ADP in place of ATP, no 
release was observed (Fig. 6A). The same effect 
of pre-incubation of the loaded CCT complex 
with AMP-PNP was exhibited for release of 
488Act1 as demonstrated by native PAGE 
analysis (Fig. 6, B and C), with virtually all 
488Act1 released from CCT and returned to its 
native state within 5 minutes of addition of ATP 
compared with 10 to 15 minutes with ATP 
alone.  
 
DISCUSSION 
Conformational changes at the C-terminus of 
actin during folding. The selective labeling of 
actin at its C-terminal cysteine is useful for 
observing changes in conformation of this 
flexible region of the protein. Labeling of 
Cys374 with bulky fluorophores has an effect on 
the local structure of the amino acid within the 
actin molecule (16), with the label acting as a 
mutation which destabilizes the actin molecule 
sufficiently to allow chemical unfolding over a 
shorter time scale. It should be noted that 
chemically unfolded actin, not nascent actin, has 
been used in these assays, and the solution 
structures of these two denatured actin states, 
which are unknown, may well differ (12). 
Nonetheless, binding of the fluorescently labeled 
actin to DNase I and VDBP and its ability to 
polymerize demonstrates that neither the 
introduction of the fluorophore, nor the manner 
of unfolding of actin, prevents folding of actin to 
a functional monomer.  
The proximity of the probe to the hinge region in 
the actin monomer makes it ideal for monitoring 
folding since EM structures demonstrate that 
actin bound to CCT takes on a more open 
structure, with the large and small domains 
binding in a 1,4 conformation across the cavity 
connected only by this hinge (17). It has also 
been hypothesised that reconfiguration of the C-
terminus is an important step in the chaperone-
mediated folding of actin (18). The contribution 
of the C-terminus to the stability of Act1 is 
clearly reflected in the variability of folding and 
unfolding behaviours depending on the nature of 
modification at Cys374. The inability of CCT to 
refold AEDANSAct1, while 488Act1 and AcrylAct1 
can be refolded, demonstrates that the nature of 
the probe attached to the surface is very 
important and provides further evidence towards 
the role of the C-terminus both in the folding and 
the stability of native actin.  
Interestingly, the acrylodan moiety is located in 
a less polar environment in both the unfolded I3 
intermediate and in F-actin relative to G-actin. 
This demonstrates the differences in 
conformation between the monomeric and 
polymeric actin states, but also similarities 
between unfolded actin and F-actin. Perhaps F-
actin re-explores the unfolding landscape of 
actin during its functional cycles as proposed by 
Altschuler and Willison (19). CCT subunits have 
been shown to associate with the F-actin 
filaments, which may indicate exposure of 
similar aggregation-prone, CCT-binding regions 
in both the unfolded and polymerized actin (20).  
Actin Folding by CCT4anc2. The G345D 
mutation in CCT4anc2 affects the inter-ring 
allostery of the chaperonin, and results in a 
slower rate of ATP hydrolysis (15). Actin 
folding by CCT4anc2 is defective in vivo above 
the permissive temperature of 30°C, with actin 
aggregates being observed in cells (9). Folding 
assays with radiolabeled human β-actin 
demonstrated that while the rate of actin folding 
by CCT4anc2 is similar to that of wild-type 
CCT, there is an approximately two-fold 
reduction in the yield of native actin (15). The 
data obtained from spectroscopic folding assay 
in general agrees with this, with the rate of actin 
release by the mutant affected by both changes 
in ATP concentration and temperature. A drop in 
the rate of actin release by CCT4anc2 is 
observed above the permissive temperature 
(highlighted in Fig. 5) and is more pronounced 
in the presence of 4 mM ATP compared to 2 
mM ATP. We note that the intracellular 
concentrations of ATP in S. cerevisiae ranges 
from 1.1 to 4.5 mM (21) and therefore the 
maximum attainable level of activity of the 
enzyme may be being reached at 37°C in 4 mM 
ATP and hence the maximum effect of the anc2 
mutation should be observed at these extremes 
(Fig. 5). Nevertheless it is striking that the range 
of activity varies only two-fold over this 
physiological relevant range of both nucleotide 
concentration and temperature. A lower yield of 
native actin is observed in the presence of 
CCT4anc2 compared to with CCT (data not 
shown), but it is unclear whether this is due to a 
decrease in loading of the unfolded actin, less 
effective release from the chaperonin or a 
combination of the two. 
Mechanism of Actin Folding by CCT. The C-
terminus of Act1 appears to be in a very similar 
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environment in both the unfolded AcrylAct1I3 and 
AcrylAct1-CCT based on the acrylodan emission 
spectra. This is the case for both the nucleotide-
free and AMP-PNP bound AcrylAct1-CCT 
complexes, so it seems probable that no 
significant conformational rearrangement at the 
C-terminus of actin occurs upon binding of 
AMP-PNP and closure of the lid of the 
chaperonin (22). The differing kinetics of ATP-
dependent release of native AcrylAct1 from CCT 
when pre-incubated with AMP-PNP relative to 
direct release from the complex indicates that a 
conformational change in actin does occur upon 
lid closure which corresponds to an initial 
folding step that is independent of the C-
terminus of actin.  
Neirynck et al (18) developed a multi-step model 
for the CCT-mediated folding of human β-actin 
based on their analysis of mutants from an 
alanine scan of the entire actin polypeptide chain 
and previous structural electron microscopy 
models of CCT-actin complexes (17, 22). Their 
model proposes two major transitions. During 
transition 1, the CCT-captured, extended form of 
actin rotates about the interdomain hinge region 
and rebinds as a more compact actin mass, as 
observed after closure of the CCT cavity by 
AMP-PNP (22). During transition 2, the actin C-
terminus which is still in direct contact with a 
CCT-subunit binding site, is released from CCT 
to establish its correct contacts with subdomain 1 
of actin and this step completes folding. The 
kinetic behaviour of AcrylAct1 folding on CCT in 
the presence of AMP-PNP followed by ATP 
supports a sequential model of actin folding 
(Fig. 7). Firstly, incubation of the pre-assembled 
CCT-actin-PLP2 ternary complex in AMP-PNP 
allows actin to progress along its folding 
trajectory to a more closed state, consistent with 
both the structural (22) and Förster resonance 
energy transfer studies (23) and secondly the 
addition of ATP permits the correct packing of 
the actin C-terminus and thus release. We 
suggest that an ATP hydrolysis step by a 
particular CCT subunit(s) is required for C-
terminal release which is why AMP-PNP does 
not facilitate this process.  
The reduced polarity of the environment 
surrounding the probe in the AcrylAct1-CCT 
complex and the similarity of the emission 
spectra to that of acrylodan labeled rabbit F-actin 
(14) suggests that the C-terminus is unlikely to 
be ‘free’ in solution. Instead, it is likely to be 
fixed somewhere, probably on a particular CCT 
subunit binding site, and as such the acrylodan 
fluorescence remains unaffected by the 
preliminary folding step induced by binding of 
AMP-PNP. The acrylodan moiety could be 
tethered to CCT in this preliminary folding step, 
or bound to the actin molecule itself. This CCT-
actin folding intermediate complex can convert 
actin into its native form through rearrangement 
at the C-terminus of actin, perhaps locking the 
molecule into the correct conformation. This 
native or native-like conformation would be 
released from the post-ATP hydrolysis, ADP 
state of CCT which could no longer bind it as it 
was no longer in a non-native conformation.  
Based on the relative rates with or without pre-
incubation with AMP-PNP, it appears that a 
slow rearrangement takes place upon binding of 
the nucleotide to CCT. This rearrangement does 
not include the labeled C-terminus, and most 
likely would be observed as a lag phase in the 
initial stages of the folding reaction which could 
well be masked in this analysis by the mixing 
period observed initially. Development of the 
spectroscopic folding assay for analysis by 
stopped flow might allow further insight into this 
stage of the reaction. This is followed by a more 
rapid rearrangement of the C-terminus as ATP is 
hydrolysed. 
The mechanism by which ATP displaces AMP-
PNP in the chaperone complex is as yet 
unknown. Due to the variation in ATP binding 
sites across the subunits of CCT, it is possible 
that AMP-PNP is not bound at all the potential 
ATP binding sites within the chaperone. Binding 
and hydrolysis of ATP at an unoccupied site 
could then bring about the allosteric 
rearrangement required to instigate the final 
folding step and release of actin. Alternatively, 
the release process could be dependent on the 
dissociation rate of AMP-PNP and subsequent 
binding of ATP.  
The folding of actin by CCT is undoubtedly an 
intricate process and is likely to be composed of 
many further rearrangements before the native 
actin monomer can be released, and more work 
is required to characterize the elaborate folding 
pathway of actin and the contribution of 
cofactors such as PLP2. Here we have shown 
evidence that an actin folding intermediate can 
be trapped within a functional folding cycle, 
elucidating the importance of the packing of the 
C-terminal of actin as a final step in the folding 
process in order to ensure release of native actin 
from CCT.  
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488, Alexa Fluor 488; Acryl, Acrylodan; Act1, yeast actin; ActA, rabbit skeletal muscle α-actin; 
AMP-PNP, adenylyl-imidodiphosphate; CBP, calmodulin binding peptide; CCT, chaperonin 
containing TCP1;  IAEDANS, 5-((2-((iodoacetyl)amino)ethyl)amino)naphthalene-1-sulfonic acid, 
PLP2, phosducin-like protein 2; VDBP, Vitamin D binding protein. 
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FIGURE LEGENDS 
Fig. 1. The crystal structure of G-actin (1), with ADP (light blue) and Ca2+ (orange) bound. Actin is 
labelled at C374 with tetramethylrhodamine (purple). 
 
Fig. 2. (A) Fluorescence emission spectra of AcrylAct1NAT (---), AcrylAct1I3 (―) and 
AcrylAct1-CCT (…) 
exciting at 380 nm; (B) Polymerisation of AcrylAct1: fluorescence emission spectra of AcrylAct1 
immediately after addition of MgCl2 and ATP (---) and after 10 minutes polymerisation (―); (C) 
Representative scan showing the change in acrylodan emission at 470 nm as AcrylAct1 is unfolded in 
the presence of 10 %v/v glycerol. 
 
Fig. 3. (A) and (B) Time course of ATP-dependent release of (A) 488Act1 and (B) AcrylAct1 from CCT. 
Act1 is unfolded onto CCT in the presence of EDTA and released by addition of 2 mM ATP and 10 
mM MgCl2. The time is shown in minutes following addition of ATP. In the final lane the formation 
of native actin is confirmed by binding to DNase I (D) and VDBP (V) as shown by a shift on the 
native gel. Coomassie stained native gels are shown on the left hand side as well as in-gel 
fluorescence of (A) 488Act1 (imaged on Typhoon 9410) and (B) AcrylAct1 (imaged by UV lamp) of the 
same gel on the right hand side. Unlabelled PLP2 is visible as marked by ?; (C) In-gel fluorescence 
by UV lamp of the release of AcrylAct1 and AcrylActA from CCT, showing native actin (N), EDTA 
unfolded actin  (U), and the time in minutes after addition of 2 mM ATP and 10 mM MgCl2 to CCT-
bound actin. AcrylActANAT is not released from CCT; (D) Refolded 488Act1 and AcrylAct1 can be co-
polymerized with unlabeled Act1, as can be shown by centrifugation at 100 000 x g of these 
filaments. The Coomassie stained SDS gel is shown on the left hand side, followed by in-gel 
fluorescence of 488Act1 and AcrylAct1. A small amount of aggregated CCT, formed overnight during 
the actin polymerisation step, pellets. 
 
 
Fig.4. (A) Representative scan of fluorescence emission of AcrylAct1 at 470 nm following release from 
CCT with 2 mM ATP, 10 mM MgCl2, fitted to a single exponential to allow the rate constant k to be 
determined; (B) Arrhenius plot of the rate constants for release of AcrylAct1 from CCT with 1 mM 
ATP, 5 mM MgCl2 (circles), 2 mM ATP, 10 mM MgCl2 (squares) or 4 mM ATP, 20 mM MgCl2 
(diamonds). Error bars show the standard deviation. 
 
Fig. 5. Arrhenius plot of the rate constants for release of AcrylAct1 from CCT4anc2 in the presence of 4 
mM ATP (open circles) or 2 mM ATP (solid circles). Temperatures of 35°C and higher are non-
permissive in vivo in CCT4anc2 (9). Error bars show the standard deviation. 
 
Fig. 6. (A) Representative scans of the fluorescence emission at 470 nm for incubation of AcrylAct1-
CCT with AMP-PNP followed by addition of ADP (triangles), and release of AcrylAct1 from CCT by 
addition of ATP following pre-incubation in the presence (solid circles) or absence (open circles) of 
AMP-PNP; (B) In-gel fluorescence of a native gel showing release of 488Act1 from CCT, showing 
488Act1 unfolded onto CCT (U), then incubation of this complex for 10 minutes with AMP-PNP and 
time points following addition of ATP to allow release of 488Act1NAT; (C) quantification of the 
488Act1NAT band from the gel (B). 
 
Fig. 7. Schematic representation of the proposed model of AcrylAct1 unfolding and binding to CCT. 
The fluorescent probe is in a more polar environment in native actin than in the EDTA-unfolded 
intermediate I3 and in the complex with CCT. (A) Actin binds in a 1,4-conformation across the cavity 
of the open CCT complex (black)  as shown by EM (17). (B) Binding of ATP or AMP-PNP closes the 
lid of CCT (gray). Step 1: Nucleotide binding induces a conformational change within the actin 
molecule (23), but does not facilitate release and the environment of the C-terminus remains 
unaffected. Step 2: Hydrolysis of ATP is required for the final packing of the actin C-terminus and 
release of native actin from CCT.  
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